Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study
This study suggests that fuquinitinib can improve the survival of patients with metastatic colorectal cancer. Patients with high levels of PNI have a better prognosis and longer survival time, ensuring the nutritional status of patients can be a help to improve the treatment of fuquinitinib.
Authors
- Xiaofang Zhou (ORCID: https://orcid.org/0000-0001-6343-1455)
- Zeng Wang
- Guonong Yang
- Sining Zhao
- Meiqin Yuan (ORCID: https://orcid.org/0000-0001-8062-0952)
- Xinyi Mao (ORCID: https://orcid.org/0009-0005-5025-5700)
- Xuan Zhang (ORCID: https://orcid.org/0009-0008-6030-0570)
Institutions
- Zhejiang Chinese Medical University (CN)
- Chinese Academy of Sciences (CN)
- Zhejiang Cancer Hospital (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2024-11-29
- DOI
- https://doi.org/10.7717/peerj.18565
- Citations
- 3
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Science Foundation
- National Natural Science Foundation of China